Except in a few cases, tumors with EGFR or ALK mutations showed a linear connection between 22C3 and SP263, which is likely attributable to high levels of PD-L1 expression in lung cancer samples with driver mutations like EGFR or ALK mutations [23,24,25]. The gene discussed is ALK; the disease is lung carcinoma.